Becton, Dickinson & Co. (BDX)
215.71
+1.19
(+0.55%)
USD |
NYSE |
Nov 12, 16:00
215.71
0.00 (0.00%)
Pre-Market: 20:00
Becton, Dickinson EPS Diluted (Quarterly) : 2.540 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.540 |
| June 30, 2026 | 1.370 |
| March 31, 2026 | -1.108 |
| December 31, 2025 | 1.336 |
| September 30, 2025 | 1.717 |
| June 30, 2025 | 1.998 |
| March 31, 2025 | 1.070 |
| December 31, 2024 | 1.043 |
| September 30, 2024 | 1.449 |
| June 30, 2024 | 1.678 |
| March 31, 2024 | 1.850 |
| December 31, 2023 | 0.9643 |
| September 30, 2023 | 0.369 |
| June 30, 2023 | 1.361 |
| March 31, 2023 | 1.533 |
| December 31, 2022 | 1.703 |
| September 30, 2022 | 0.9247 |
| June 30, 2022 | 1.281 |
| March 31, 2022 | 1.500 |
| December 31, 2021 | 2.284 |
| September 30, 2021 | 0.8385 |
| June 30, 2021 | 1.316 |
| March 31, 2021 | 0.9436 |
| December 31, 2020 | 3.347 |
| September 30, 2020 | 0.358 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.9714 |
| March 31, 2020 | 0.5272 |
| December 31, 2019 | 0.8729 |
| September 30, 2019 | 0.41 |
| June 30, 2019 | 1.51 |
| March 31, 2019 | -0.07 |
| December 31, 2018 | 2.05 |
| September 30, 2018 | -0.64 |
| June 30, 2018 | 2.03 |
| March 31, 2018 | -0.19 |
| December 31, 2017 | -0.76 |
| September 30, 2017 | 1.24 |
| June 30, 2017 | -0.75 |
| March 31, 2017 | 1.58 |
| December 31, 2016 | 2.58 |
| September 30, 2016 | 0.09 |
| June 30, 2016 | 1.794 |
| March 31, 2016 | 1.56 |
| December 31, 2015 | 1.06 |
| September 30, 2015 | 0.84 |
| June 30, 2015 | 0.29 |
| March 31, 2015 | 1.08 |
| December 31, 2014 | 1.20 |
| September 30, 2014 | 1.53 |
| June 30, 2014 | 1.65 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5294 |
| Boston Scientific Corp. | 0.4008 |
| Globus Medical, Inc. | 1.038 |
| Stryker Corp. | 1.957 |
| Baxter International, Inc. | 0.5654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 696.00M |
| Revenue (Quarterly) | 5.274B |
| Total Expenses (Quarterly) | 4.578B |
| Enterprise Value | 74.08B |
| Gross Profit Margin (Quarterly) | 51.06% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 1.92% |
| Operating Earnings Yield | 5.42% |
| Normalized Earnings Yield | 2.857 |